Bayer Invests in GRO Biosciences’ Pioneering Protein Therapeutics Efforts

Bayer is investing in GRO Biosciences, a Boston-based company that is developing protein therapeutics for patients with autoimmune and metabolic diseases.
Source: Drug Industry Daily